Literature DB >> 27859643

Undernourishment in utero and hepatic steatosis in later life: A potential issue in Japanese people.

Hiroaki Itoh1, Keiko Muramatsu-Kato1, Urmi J Ferdous1, Yukiko Kohmura-Kobayashi1, Naohiro Kanayama1.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) is a hepatic manifestation of metabolic syndrome. The prevalence of NAFLD in Japan has nearly doubled in the last 10-15 years. Increasing evidence supports undernourishment in utero being causatively connected with the risk of NAFLD in later life. Low body mass index (BMI) has been common among Japanese women of childbearing age for several decades due to their strong desire to be thin. It is plausible that insufficient maternal energy intake by pregnant Japanese women may underlie the rapid increase in the prevalence of NAFLD in Japan. In order to clarify the mechanisms by which undernourishment in utero primes adult hepatic steatosis, we developed a mouse model of fetal undernourishment with a hepatic fat deposit-prone phenotype on an obesogenic high fat diet in later life. We found that endoplasmic reticulum (ER) stress response parameters were activated concomitantly with the deterioration of hepatic steatosis and also that the alleviation of ER stress with the chemical chaperone, tauroursodeoxycholic acid (TUDCA), significantly improved hepatic steatosis. Therefore, undernourishment in utero may program the future integration of ER stress in the liver on an obesogenic diet in later life and also induce the deterioration of hepatic steatosis. These results also provide an insight into interventions for the potential high-risk population of NAFLD, such as those born small or exposed to maternal undernourishment during the fetal period, with the alleviation of ER stress by dietary supplements and/or specific food including chaperones.
© 2016 Japanese Teratology Society.

Entities:  

Keywords:  developmental origins of health and disease; low birthweight; metabolic syndrome; nonalcoholic fatty liver disease; pregnancy

Mesh:

Substances:

Year:  2017        PMID: 27859643     DOI: 10.1111/cga.12200

Source DB:  PubMed          Journal:  Congenit Anom (Kyoto)        ISSN: 0914-3505            Impact factor:   1.409


  4 in total

1.  Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non-alcoholic fatty liver disease.

Authors:  Weijun Wang; Jinfang Zhao; Wenfang Gui; Dan Sun; Haijiang Dai; Li Xiao; Huikuan Chu; Fan Du; Qingjing Zhu; Bernd Schnabl; Kai Huang; Ling Yang; Xiaohua Hou
Journal:  Br J Pharmacol       Date:  2018-01-03       Impact factor: 8.739

2.  Excessive folic acid supplementation in pregnant mice impairs insulin secretion and induces the expression of genes associated with fatty liver in their offspring.

Authors:  Yuri Kintaka; Nobuhiro Wada; Seiji Shioda; Sadako Nakamura; Yuko Yamazaki; Kazuki Mochizuki
Journal:  Heliyon       Date:  2020-04-18

3.  Gestation Food Restriction and Refeeding Compensate Maternal Energy Status and Alleviate Metabolic Consequences in Juvenile Offspring in a Rabbit Model.

Authors:  Rosa M Garcia-Garcia; María Arias-Alvarez; Pilar Millan; María Rodriguez Francisco; Ana Sanchez Rodriguez; Pedro L Lorenzo; Pilar G Rebollar
Journal:  Nutrients       Date:  2021-01-22       Impact factor: 5.717

4.  Fetal alcohol spectrum disorder predisposes to metabolic abnormalities in adulthood.

Authors:  Olivia Weeks; Gabriel D Bossé; Isaac M Oderberg; Sebastian Akle; Yariv Houvras; Paul J Wrighton; Kyle LaBella; Isabelle Iversen; Sahar Tavakoli; Isaac Adatto; Arkadi Schwartz; Daan Kloosterman; Allison Tsomides; Michael E Charness; Randall T Peterson; Matthew L Steinhauser; Pouneh K Fazeli; Wolfram Goessling
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.